Loading clinical trials...
Loading clinical trials...
The aim of this study is to investigate whether pharmacological pre-treatment with levosimendan reduces intensive care unit (ICU) length of stay in patients undergoing elective myocardial revasculariz...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Roma La Sapienza
Collaborators
NCT07358221 · Coronary Artery Bypass Grafting (CABG) Surgery, Myocardial Protection
NCT03859115 · Myocardial Protection
NCT01941420 · Aortic Stenosis, Myocardial Protection
University of Rome "Sapienza"
Rome
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions